ACP-01 in Patients With Critical Limb Ischemia

Summary

The primary objective of this study is to determine the efficacy and safety of intramuscular injection of ACP-01, comprised of blood-derived autologous ACPs, in subjects with critical limb ischemia who are receiving standard of care therapy and have no endovascular or surgical revascularization options.

Timeline

Start

2014-08

Primary completion

2020-04

Completion

2021-04

Drugs

Indications